|
⚲
|
| Keyboard |
| Karl Handelsman | |
|---|---|
| Firm | Codon Innovation LLC |
| Address | 48 Fort Mason San Francisco, CA 94123 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Codon Innovation LLC | |||||
| Codon Innovation Fund I LP | 021-485213 | Executive Officer | 12.4 M of 15.0 M |
7.5 M | |
| Bonum Therapeutics Inc | 021-465970 | Director | 45.0 M of 93.0 M |
||
| Bonum Therapeutics Inc | 021-426281 | Director | 1.2 M of 3.6 M |
||
| Good Therapeutics Inc | 021-426282 | Director | 8.8 M of 26.4 M |
||
| Codon Capital Fund I LP | 021-390843 | Director | of 50.0 M |
||
| Good Therapeutics Inc | 021-326349 | Director | 22.3 M of 22.3 M |
||
| Neos Therapeutics Inc | 021-181321 | Director | 18.3 M of 30.0 M |
||
| Neos Therapeutics Inc | 021-161023 | Director | 13.6 M of 20.0 M |
||
| Tetraphase Pharmaceuticals Inc | 021-142724 | Director | 44.8 M of 45.0 M |
||
| Tetraphase Pharmaceuticals Inc | 021-94056 | Director | 10.0 M of 29.6 M |
||
| Intellikine Inc | 021-132390 | Director | 16.0 M of 38.5 M |
||
| Neos Therapeutics Inc | 021-132428 | Director | 24.2 M of 50.0 M |
||